Biotech Medics Ne (BMCS) Stock Price, Chart & News

Up to 60% off Profit Pro - Limited to first 500 users

Black Friday Sale

Up to 60% off Profit Pro - Limited to first 500 users

60% off Profit Pro - Limited to first 500 users

BMCS

0.02

USD0.0023.33%

Overview

Profile

Statistics

Earnings

Financials

Filings

News

Chart

Latest News

Seeking Alpha

2 years

US Energy Initiatives transfers $10M digital assets to BMCS SUMCOIN INDEX FUND

Day Range

0.02USD

52 Week Range

0.00USD

0.05USD

Market Cap

3.08MUSD

About

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

General Information

Type

Common Stock

Exchange

PINK

Currency Code

USD

Currency Name

US Dollar

Country Name

USA

Country ISO

ISIN

US0906993078

CUSIP

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Fiscal Year End

December

IPO date

Updated At

Highlights

PE Ratio

PEG Ratio

Book Value

0.02

Dividend Share

Dividend Yield

Earnings Share

-0.004

Wall Street Target Price

EPS Estimate Current Year

EPS Estimate Next Year

EPS Estimate Current Quarter

EPS Estimate Next Quarter

Most Recent Quarter

Profitability

Revenue TTM

469,799

Gross Profit TTM

408,137

EBITDA

33,355

Profit Margin

-128.51%

Return On Assets TTM

0.00%

Return On Equity TTM

0.00%

Revenue Per Share TTM

0.003

Qtly Revenue Growth YOY

0.00%

Diluted Eps TTM

-0.004

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

Price Sales TTM

8.0866

Price Book MRQ

Enterprise Value Revenue

Enterprise Value EBITDA

Peers analysis

TEVATeva Pharma Industries Ltd ADR
16.84
1.63%
VTRSViatris Inc
13.35
1.02%
TAKTakeda Pharmaceutical Co Ltd ADR
13.62
0.22%
MKKGYMerck KGaA ADR
29.89
0.10%
TEVJFTeva Pharmaceutical Industries Limited
15.78
0.00%

TKPHFTakeda Pharmaceutical Co. Ltd.
25.40
-8.10%
MKGAFMERCK Kommanditgesellschaft auf Aktien
144.75
-3.82%
Sa
SDZNYSandoz Group AG
45.38
-1.24%
HLNHaleon plc
9.62
-1.13%
ZTSZoetis Inc
175.25
-0.91%

What are you waiting for?Start making profit today

Tools

Plans

Markets

Resources

Compare

Profit mobile app

Discover the world of finance in your pocket

2024